FDA Import Refusal 112-1153647-5/1/1 — Mercury Pharma Group Limited
The FDA refused shipment 112-1153647-5/1/1 from Mercury Pharma Group Limited (United Kingdom) on Mar 1, 2013. The refused product falls under Drugs and Biologics — METHOTREXATE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 1 other import refusal on record.
Refusal details
- Date
- Mar 1, 2013
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 62ICA31 METHOTREXATE (ANTI-NEOPLASTIC)
- Charges
- 75